homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

November 14, 2023

Know Labs

Seattle-based Know Labs, an emerging developer of non-invasive medical diagnostic technology, appointed three new members to its board, increasing the number of directors to seven. The new appointees are John Cronin, Larry Ellingson and Tim Londergan. Cronin is the founder and CEO of ipCapital Group, a global advisory company on intellectual property strategy and monetization. Cronin began his career at IBM where he was the sole inventor of breakthrough chip design technology. He went on to create the IBM Patent Factory and grew IBM's patent portfolio from ninth to number one in the world. Ellingson has been a member of Know Labs' Medical Advisory Board for the past four years. Ellingson's background includes 30 years with Eli Lilly where he headed the multibillion-dollar annual revenue Diabetes Care business unit. Ellingson has been an advocate for accessible and affordable diagnosis and treatment through his activities with diabetes focused nonprofit organizations. Londergan is the founder and CEO of Tangibly, developer of a trade secret management platform. Londergan has experience as a CEO and COO of technology companies, including Lumera, Wavefront Venture Labs and Operem. He spent several years as head of commercial development at Intellectual Ventures, a global intellectual property fund.




Email or user name:
Password:
 
Forgot password? Click here.